{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:47:00Z","timestamp":1790444820732,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Marshall B. Ketchum University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtos.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:57:18Z","timestamp":1749898638000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A pilot randomized controlled trial of topical androgen treatment in dry eye"],"prefix":"10.1016","volume":"38","author":[{"given":"Jay Ruzhang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Khankan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William H.","family":"Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Loc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry R.","family":"Paugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2025.06.002_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.06.002_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II sex, gender, and hormones report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.06.002_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1507\/endocrj.EJ20-0178","article-title":"The applications of androgen in the treatment of dry eye disease: a systematic review of clinical studies","volume":"67","author":"Wang","year":"2020","journal-title":"Endocr J"},{"key":"10.1016\/j.jtos.2025.06.002_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20540","article-title":"Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome","volume":"51","author":"Pillemer","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jtos.2025.06.002_bib5","article-title":"A multi-center, double-masked, randomized, vehicle-controlled, parallel group study to evaluate the safety and efficacy of testosterone ophthalmic solution in patients with Meibomian gland dysfunction","volume":"47","author":"Schiffman","year":"2006","journal-title":"IOVS (Investig Ophthalmol Vis Sci)"},{"key":"10.1016\/j.jtos.2025.06.002_bib6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/bjophthalmol-2016-309498","article-title":"The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study","volume":"101","author":"Golebiowski","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.06.002_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajo.2018.09.021","article-title":"A randomized controlled double-masked study of transdermal androgen in dry eye patients associated with androgen deficiency","volume":"197","author":"Supalaset","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.06.002_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-5122(00)00181-X","article-title":"Treatment of keratoconjunctivitis sicca with topical androgen","volume":"37","author":"Worda","year":"2001","journal-title":"Maturitas"},{"key":"10.1016\/j.jtos.2025.06.002_bib9","article-title":"Treatment of dry eye with a transdermal 3% testosterone cream","volume":"44","author":"Connor","year":"2003","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2025.06.002_bib10","article-title":"Evaporative dry eye treated with transdermal testosterone","volume":"49","author":"Connor","year":"2008","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2025.06.002_bib11","article-title":"Androgenic cream treatment Most efficacious for women 40 to 60 with dry eye","volume":"50","author":"Connor","year":"2009","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2025.06.002_bib12","article-title":"Symptomatic relief of dry eye assessed with the OSDI in patients using 5% testosterone cream","volume":"46","author":"Connor","year":"2005","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2025.06.002_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.06.002_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4085\/1062-6050-43.2.215","article-title":"Issues in outcomes research: an overview of randomization techniques for clinical trials","volume":"43","author":"Kang","year":"2008","journal-title":"J Athl Train"},{"key":"10.1016\/j.jtos.2025.06.002_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.11.2.27","article-title":"Validation of the modified schein dry eye symptom questionnaire and comparison with the ocular surface disease index","volume":"11","author":"Paugh","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2025.06.002_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2025.06.002_bib17","first-page":"221","volume":"21","author":"Lemp","year":"1995"},{"key":"10.1016\/j.jtos.2025.06.002_bib18","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2025.06.002_bib19","first-page":"243","article-title":"Meibomian gland dysfunction and contact lens intolerance","volume":"51","author":"Korb","year":"1980","journal-title":"J Am Optom Assoc"},{"key":"10.1016\/j.jtos.2025.06.002_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bjo.65.1.2","article-title":"The questionable dry eye","volume":"65","author":"Mackie","year":"1981","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.06.002_bib21","series-title":"Package insert","year":"2021"},{"key":"10.1016\/j.jtos.2025.06.002_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1542-0124(12)70084-8","article-title":"Design and conduct of clinical trials: report of the clinical trials subcommittee of the international dry eye workshop","volume":"5","author":"Tsubota","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2025.06.002_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/bjophthalmol-2013-304637","article-title":"Transdermal androgen patches in evaporative dry eye syndrome with androgen deficiency: a pilot study","volume":"98","author":"Nanavaty","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2025.06.002_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ophtha.2018.09.008","article-title":"Choosing core outcomes for use in clinical trials in ophthalmology: perspectives from three ophthalmology outcomes working groups","volume":"126","author":"Saldanha","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2025.06.002_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/frne.2001.0216","article-title":"DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology","volume":"22","author":"Labrie","year":"2001","journal-title":"Front Neuroendocrinol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012425000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T09:57:05Z","timestamp":1764755825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012425000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"alternative-id":["S1542012425000801"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2025.06.002","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot randomized controlled trial of topical androgen treatment in dry eye","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}